Acrivon Therapeutics所有資訊

Acrivon Therapeutics | EFFECT：其他

04/30 06:11 (美東)

Acrivon Therapeutics | ARS：年度報告

04/26 08:38 (美東)

Acrivon Therapeutics | DEFA14A：其他

04/26 08:38 (美東)

Acrivon Therapeutics | DEF 14A：股東委託書決議

04/26 08:33 (美東)

Acrivon Therapeutics | 8-K：重大事件

04/24 16:06 (美東)

Acrivon Therapeutics | 4：持股變動聲明-高管 Miller Mary

04/19 16:15 (美東)

Acrivon Therapeutics | S-3：特定交易註冊聲明

04/17 16:41 (美東)

Acrivon Therapeutics | 4：持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.

04/15 16:20 (美東)

Acrivon Therapeutics | 4：持股變動聲明-股東 PERCEPTIVE ADVISORS LLC

04/15 08:58 (美東)

Acrivon Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%)等

04/15 08:23 (美東)

Acrivon Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%)等

04/11 16:22 (美東)

Acrivon Therapeutics | 8-K：重大事件

04/09 07:09 (美東)

Acrivon Therapeutics | S-8：員工福利計劃證券登記

03/29 09:07 (美東)

Acrivon Therapeutics | 8-K：Acrivon Therapeutics公佈2023年第四季度和全年財務業績和業務亮點

03/28 08:04 (美東)

Acrivon Therapeutics | 10-K：年度報表

03/28 07:39 (美東)

Acrivon Therapeutics | 4：持股變動聲明-董事 Palani Santhosh

03/06 16:36 (美東)

Acrivon Therapeutics | 3：首次持股聲明-董事 Palani Santhosh

03/06 16:31 (美東)

Acrivon Therapeutics | 8-K：重大事件

03/04 08:20 (美東)

Acrivon Therapeutics | 4：持股變動聲明-高管 Masson Kristina

02/16 17:19 (美東)

Acrivon Therapeutics | 4：持股變動聲明-高管 Miller Mary

02/16 17:18 (美東)